Products for Research Use Only
RegisterLogin

AM966

CAT: 0013-GTR19161046-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19161046-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AM966 is a potent, selective and orally active LPA (1) receptor antagonist which inhibits lung fibrosis in the mouse bleomycin model.Last. In vitro, AM966 inhibited LPA-stimulated intracellular calcium release (IC (50) = 17 nM) from Chinese hamster ovary cells stably expressing human LPA (1) receptors and inhibited LPA-induced chemotaxis (IC (50) = 181 nM) of human IMR-90 lung fibroblasts expressing LPA (1) receptors. AM966 demonstrated a good pharmacokinetic profile following oral dosing in mice. In the mouse, AM966 reduced lung injury, vascular leakage, inflammation and fibrosis at multiple time points following intratracheal bleomycin instillation. AM966 also decreased lactate dehydrogenase activity and tissue inhibitor of metalloproteinase-1, transforming growth factor beta1, hyaluronan and matrix metalloproteinase-7, in bronchoalveolar lavage fluid.
CAS Number
1228690-19-4
Product Name Alternative
AM-966 | AM 966 | AM966
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 105 mg/mL. 213.88 mM
Smiles
O=C (O) CC (C=C1) =CC=C1C (C=C2) =CC=C2C3=C (NC (O[C@H] (C) C4=C (Cl) C=CC=C4) =O) C (C) =NO3
Molecular Formula
C27H23ClN2O5
Molecular Weight
490.94
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(4'- (4- ((R) -1- (2-Chlorophenyl) ethoxycarbonylamino) -3-methylisoxazol-5-yl) biphenyl-4-yl) acetic acid

Alternative Products

CatalogName
A3170-5AM966
A13982-100AM966 100mg
A13982-200AM966 200mg
A13982-50AM966 50mg
A13982-25AM966 25mg
A13982-10AM966 10mg
A13982-5AM966 5mg
A13982-10mM-DAM966 10mM * 1mL in DMSO

Popular Products